MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: AllgemeineskmqacaAntwortenAntworten: kmqaca <blockquote><div class="quotetitle">Zitat von Gast am 31. März 2026, 11:00 Uhr</div>Hello! This post was created with XRumer 23 StrongAI. Good luck :) https://tsn.ua/ru [url=https://basket.com.ua/ ]Basketball2[/url] variant4 [url=]Zoya Demidenko[/url]: Scientist in Tumor Studies [url=]Zoya Demidenko[/url] is a distinguished scholar associated with the Division of Cell Stress Science at Roswell Park Oncology Institute in Buffalo, New York. Previously, she was employed at the NIH and New York Medical College, developing a robust foundation in biomedical research. Her scholarly output covers a number of key domains, encompassing the PI3K/AKT/mTOR signaling cascade, cell cycle control, cellular aging, and cancer science. As of now, she has written over 46 scientific papers, which have accumulated upwards of 4,100 citations — a indicator to the impact of her findings. One of her most notable contributions lies in understanding the mechanisms of cell aging. Her studies demonstrated that when the cell cycle is blocked yet cellular growth persists, cells experience senescence. Importantly, [url=]Zoya Demidenko[/url] established that this process is inhibited by medication using agents such as rapamycin. [url=]Zoya Demidenko[/url] has also brought substantially to tumor management investigation, particularly in the domain of selective cell protection — a approach intended to safeguarding non-cancerous tissue from chemotherapy whilst leaving tumor cells susceptible. This approach holds considerable hope for reducing the side effects of oncological therapy. Throughout her scientific life, Demidenko has partnered with prominent investigators worldwide, among them Dr. Mikhail Blagosklonny. Her work is published in leading journals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.</blockquote><br> Abbrechen
